These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Rational design, synthesis, and characterization of deep blue phosphorescent Ir(III) complexes containing (4'-substituted-2'-pyridyl)-1,2,4-triazole ancillary ligands.
    Author: Park HJ, Kim JN, Yoo HJ, Wee KR, Kang SO, Cho DW, Yoon UC.
    Journal: J Org Chem; 2013 Aug 16; 78(16):8054-64. PubMed ID: 23865939.
    Abstract:
    On the basis of the results of frontier orbital considerations, 4-substituted-2'-pyridyltriazoles were designed to serve as ancillary ligands in 2-phenylpyridine main ligand containing heteroleptic iridium(III) complexes that display deep blue phosphorescence emission. The iridium(III) complexes, Ir1-Ir7, prepared using the new ancillary ligands, were found to display structured, highly quantum efficient (Φp = 0.20-0.42) phosphorescence with emission maxima in the blue to deep blue 448-456 nm at room temperature. In accord with predictions based on frontier orbital considerations, the complexes were observed to have emission properties that are dependent on the electronic nature of substituents at the C-4 position of the pyridine moiety of the ancillary ligand. Importantly, placement of an electron-donating methyl group at C-4' of the pyridine ring of the 5-(pyridine-2'-yl)-3-trifluoromethyl-1,2,4-triazole ancillary ligand leads to an iridium(III) complex that displays a deep blue phosphorescence emission maximum at 448 nm in both the liquid and film states at room temperature. Finally, an OLED device, constructed using an Ir-complex containing the optimized ancillary ligand as the dopant, was found to emit deep blue color with a CIE of 0.15, 0.18, which is close to the perfect goal of 0.15, 0.15.
    [Abstract] [Full Text] [Related] [New Search]